Literature DB >> 19812154

Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.

Kirsten Hanke1, Philipp Kramer, Sandra Seeher, Nadine Beimforde, Reinhard Kurth, Norbert Bannert.   

Abstract

Endogenous retroviruses present in the human genome provide a rich record of ancient infections. All presently recognized elements, including the youngest and most intact proviruses of the human endogenous retrovirus K(HML-2) [HERV-K(HML-2)] family, have suffered postinsertional mutations during their time of chromosomal residence, and genes encoding the envelope glycoprotein (Env) have not been spared these mutations. In this study, we have, for the first time, reconstituted an authentic Env of a HERV-K(HML-2) provirus by back mutation of putative postinsertional amino acid changes of the protein encoded by HERV-K113. Aided by codon-optimized expression, we demonstrate that the reconstituted Env regained its ability to be incorporated into retroviral particles and to mediate entry. The original ancient HERV-K113 Env was synthesized as a moderately glycosylated gp95 precursor protein cleaved into surface and transmembrane (TM) subunits. Of the nine N-linked oligosaccharides, four are part of the TM subunit, contributing 15 kDa to its apparent molecular mass of 41 kDa. The carbohydrates, as well as the cytoplasmic tail, are critical for efficient intracellular trafficking, processing, stability, and particle incorporation. Whereas deletions of the carboxy-terminal 6 residues completely abrogated cleavage and virion association, more extensive truncations slightly enhanced incorporation but dramatically increased the ability to mediate entry of pseudotyped lentiviruses. Although the first HERV-K(HML-2) elements infected human ancestors about 30 million years ago, our findings indicate that their glycoproteins are in most respects remarkably similar to those of classical contemporary retroviruses and can still mediate efficient entry into mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19812154      PMCID: PMC2786854          DOI: 10.1128/JVI.01368-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.

Authors:  Terri G Edwards; Stéphanie Wyss; Jacqueline D Reeves; Susan Zolla-Pazner; James A Hoxie; Robert W Doms; Frédéric Baribaud
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

Review 2.  The evolutionary dynamics of human endogenous retroviral families.

Authors:  Norbert Bannert; Reinhard Kurth
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

3.  Insertional polymorphisms of full-length endogenous retroviruses in humans.

Authors:  G Turner; M Barbulescu; M Su; M I Jensen-Seaman; K K Kidd; J Lenz
Journal:  Curr Biol       Date:  2001-10-02       Impact factor: 10.834

4.  CD4 independence of simian immunodeficiency virus Envs is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity.

Authors:  Bridget A Puffer; Stefan Pöhlmann; Aimee L Edinger; Dan Carlin; Melissa D Sanchez; Julie Reitter; Debbie D Watry; Howard S Fox; Ronald C Desrosiers; Robert W Doms
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  HERV-K(OLD): ancestor sequences of the human endogenous retrovirus family HERV-K(HML-2).

Authors:  K Reus; J Mayer; M Sauter; H Zischler; N Müller-Lantzsch; E Meese
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses.

Authors:  N Bannert; D Schenten; S Craig; J Sodroski
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response.

Authors:  Miriam I Quiñones-Kochs; Linda Buonocore; John K Rose
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

8.  Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein.

Authors:  L Deml; A Bojak; S Steck; M Graf; J Wild; R Schirmbeck; H Wolf; R Wagner
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain.

Authors:  Felix J Kim; Nicolas Manel; Yvan Boublik; Jean-Luc Battini; Marc Sitbon
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  The conserved dileucine- and tyrosine-based motifs in MLV and MPMV envelope glycoproteins are both important to regulate a common Env intracellular trafficking.

Authors:  Vincent Blot; Sandra Lopez-Vergès; Marie Breton; Claudine Pique; Clarisse Berlioz-Torrent; Marie-Pierre Grange
Journal:  Retrovirology       Date:  2006-09-15       Impact factor: 4.602

View more
  26 in total

1.  Expression of Human Endogenous Retrovirus Type K Envelope Protein is a Novel Candidate Prognostic Marker for Human Breast Cancer.

Authors:  Jing Zhao; Kiera Rycaj; Shanshan Geng; Ming Li; Joshua B Plummer; Bingnan Yin; Hong Liu; Xu Xu; Yinchun Zhang; Yanfang Yan; Sharon A Glynn; Tiffany H Dorsey; Stefan Ambs; Gary L Johanning; Lin Gu; Feng Wang-Johanning
Journal:  Genes Cancer       Date:  2011-09

2.  Vaccination with cancer- and HIV infection-associated endogenous retrotransposable elements is safe and immunogenic.

Authors:  Jonah B Sacha; In-Jeong Kim; Lianchun Chen; Jakir H Ullah; David A Goodwin; Heather A Simmons; Daniel I Schenkman; Frederike von Pelchrzim; Robert J Gifford; Francesca A Nimityongskul; Laura P Newman; Samantha Wildeboer; Patrick B Lappin; Daisy Hammond; Philip Castrovinci; Shari M Piaskowski; Jason S Reed; Kerry A Beheler; Tharsika Tharmanathan; Ningli Zhang; Sophie Muscat-King; Melanie Rieger; Carla Fernandes; Klaus Rumpel; Joseph P Gardner; Douglas H Gebhard; Juliann Janies; Ahmed Shoieb; Brian G Pierce; Dusko Trajkovic; Eva Rakasz; Sing Rong; Michael McCluskie; Clare Christy; James R Merson; R Brad Jones; Douglas F Nixon; Mario A Ostrowski; Peter T Loudon; Ingrid M Pruimboom-Brees; Neil C Sheppard
Journal:  J Immunol       Date:  2012-06-27       Impact factor: 5.422

3.  Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Authors:  Rafael Contreras-Galindo; Mark H Kaplan; Angie C Contreras-Galindo; Marta J Gonzalez-Hernandez; Ilaria Ferlenghi; Fabiola Giusti; Eric Lorenzo; Scott D Gitlin; Michael H Dosik; Yasuhiro Yamamura; David M Markovitz
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

Review 4.  Human endogenous retrovirus-K (HML-2): a comprehensive review.

Authors:  Marta Garcia-Montojo; Tara Doucet-O'Hare; Lisa Henderson; Avindra Nath
Journal:  Crit Rev Microbiol       Date:  2018-10-14       Impact factor: 7.624

5.  Expression of HERV-K108 envelope interferes with HIV-1 production.

Authors:  Sandra N Terry; Lara Manganaro; Alvaro Cuesta-Dominguez; Daria Brinzevich; Viviana Simon; Lubbertus C F Mulder
Journal:  Virology       Date:  2017-06-09       Impact factor: 3.616

Review 6.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

7.  Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.

Authors:  Lindsey R Robinson; Sean P J Whelan
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

8.  Staufen-1 interacts with the human endogenous retrovirus family HERV-K(HML-2) rec and gag proteins and increases virion production.

Authors:  Kirsten Hanke; Oliver Hohn; Linda Liedgens; Katharina Fiddeke; Jula Wamara; Reinhard Kurth; Norbert Bannert
Journal:  J Virol       Date:  2013-08-07       Impact factor: 5.103

9.  Dysfunction of bovine endogenous retrovirus K2 envelope glycoprotein is related to unsuccessful intracellular trafficking.

Authors:  Yuki Nakaya; Takayuki Miyazawa
Journal:  J Virol       Date:  2014-04-02       Impact factor: 5.103

10.  HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.

Authors:  Daria Brinzevich; George R Young; Robert Sebra; Juan Ayllon; Susan M Maio; Gintaras Deikus; Benjamin K Chen; Ana Fernandez-Sesma; Viviana Simon; Lubbertus C F Mulder
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.